Empirical study on the anti-proliferation effect of siRNA against survivin combined with DDP on human lung cancer cell line A549

YAO Cao-yuan; et al

您当前的位置：

首页 >

文章列表页 >

Empirical study on the anti-proliferation effect of siRNA against survivin combined with DDP on human lung cancer cell line A549

更新时间：2024-01-17

- Empirical study on the anti-proliferation effect of siRNA against survivin combined with DDP on human lung cancer cell line A549
- Journal of Chongqing Medical University Vol. 34, Issue 2, Pages: 178-181(2009)
- 作者机构：
  
  1. 重庆医科大学附属第一医院呼吸内科
  2. 重庆医科大学附属第一医院普外科
- 作者简介：
- 基金信息：
- DOI：
  CLC： R734.2
- Published：2009，
扫描看全文
[1]姚草原,江涛,韩晓黎,李凡.靶向survivin的siRNA联合顺铂抑制肺腺癌A549细胞增殖的实验研究[J].重庆医科大学学报,2009,34(02):178-181.

YAO Cao-yuan, et al. Empirical study on the anti-proliferation effect of siRNA against survivin combined with DDP on human lung cancer cell line A549. [J]. Journal of Chongqing Medical University 34(2):178-181(2009)
[1]姚草原,江涛,韩晓黎,李凡.靶向survivin的siRNA联合顺铂抑制肺腺癌A549细胞增殖的实验研究[J].重庆医科大学学报,2009,34(02):178-181. DOI：

YAO Cao-yuan, et al. Empirical study on the anti-proliferation effect of siRNA against survivin combined with DDP on human lung cancer cell line A549. [J]. Journal of Chongqing Medical University 34(2):178-181(2009) DOI：

摘要

目的:研究靶向survivin的siRNA和顺铂联用对肺癌细胞A549的增殖抑制作用。方法:将A549细胞分为空白对照组

阴性对照质粒pSilencer2.0-NC转染组

顺铂处理组

pSilencer2.0-SVV2转染组

pSilencer2.0-SVV2转染+顺铂处理组。转染采用脂质体法。MTT法检测靶向survivin的siRNA和顺铂对A549细胞增殖的抑制作用;RT-PCR法检测A549细胞survivin mRNA转录水平变化情况;流式细胞术和TUNEL法检测A549细胞凋亡情况。结果:MTT法示:pSilencer2.0-SVV2转染+顺铂处理组增殖抑制率为51.38%±1.35%

与其它各组相比抑制率明显增高

具有统计学意义（P<0.05）;RT-PCR检测显示空白对照组

阴性对照质粒pSilencer2.0-NC转染组

顺铂处理组survivin mRNA表达无明显变化（P>0.05）

pSilencer2.0-SVV2转染组、pSilencer2.0-SVV2转染+顺铂处理组survivin mRNA表达明显下降（P<0.05）;流式细胞术和TUNEL法检测pSilencer2.0-SVV2转染+顺铂处理组凋亡率分别为42.48%±2.28%和40.65%±3.53%

与其它各组相比凋亡率明显增高

具有统计学意义（P<0.05）。结论:将靶向survivin的siRNA和顺铂联合应用可以协同抑制A549细胞增殖

共同发挥诱导细胞凋亡作用。

Abstract

Objective:To investigate the anti-proliferation effect of siRNA against survivin combined with DDP on human lung cancer cell line A549.Methods:A549 cells were divided into five different treatment groups:blank control group

pSilencer2.0-NC group

DDP group

pSilencer2.0-SVV2 group

and pSilencer2.0-SVV2+DDP group.LipofectamineTM 2000 was used to transfect A549 cell.The effects on cell proliferation and apoptosis were analyzed by MTT assay

flow cytometry

and TUNEL respectively.The expression of survivin mRNA was evaluated by RT-PCR experiment.Results:The MTT assay indicated that the anti-proliferation rate of pSilencer2.0-SVV2+DDP group was 51.38%±1.35%.The anti-proliferation rate of this group was higher than any other group(P<0.05).The experiment of RT-PCR showed that the expression of survivin mRNA in pSilencer2.0-SVV2 group and pSilencer2.0-SVV2+DDP group werelowerthan thatin othergroups(P<0.05)

butitslevel in blank control group

pSilencer2.0-NC group

DDP group had no marked change(P>0.05).Flow cytometry and TUNEL indicated that the apoptosis rates of pSilencer2.0-SVV2+DDP were 42.48%±2.28%and 40.65%± 3.53%respectively

higher than in any other group(sP<0.05).Conclusion:siRNA against survivin combined with DDP can enhance the inhibitory effect on lung cancer cell line A549 and induce apoptosis in common.

关键词

RNA干扰survivin基因肺肿瘤顺铂

Keywords

RNA interferenceSurvivinLung cancer cellDDP

references

Views

136

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

RNAi technology applied to the preparation of molecular probes for diagnosis and treatment of ovarian cancer

Construction of recombinant lentiviral vector of si RNA for transforming growth factor-beta typeⅠ receptor gene and its expression in human embryonic lung fibroblasts

Effect of GM130 on O-linked glycosylation and adhesion of human gastric cancer cell line MKN-45

Construction of HPV16 E6 siRNA expressing recombinants and identification of transfection efficiency in vitro

Establishment and identification of siRNA eukaryotic expression vectors of recombinant targeting gene glucocorticoid receptor

Related Author

Wu Xiaofeng

Wen Ming

Lin Shihui

Fu Juan

Wang Chuanjiang

Liu Qiong

Su Linqian

Feng Yangyang

Related Institution

Department of Radiology,The First Affiliated Hospital of Chongqing Medical University

Department of Emergency and Intensive Care Unit,The First Affiliated Hospital of Chongqing Medical University

Teaching and Research Section of Pathology,College of Basic Medicine,Molecular Medicine and Cancer Research Center,Chongqing Medical University

重庆医科大学公共卫生学院生殖医学教研室

Department of Biochemistry and Molecule Biology,College of Basic Medicine,Chongqing Medical University

⁰